AAPL 234.88 -1.257% MSFT 426.35 0.0094% NVDA 137.3 0.778% GOOGL 194.33 -0.6239% GOOG 195.93 -0.533% AMZN 222.83 -0.2328% META 612.7488 -0.7083% AVGO 235.305 3.2039% TSLA 416.28 -2.7883% TSM 217.5 5.1741% LLY 748.845 0.2819% V 318.02 0.5501% JPM 256.24 1.5415% UNH 526.4 -3.132% NVO 82.465 -0.5487% WMT 90.24 -1.2043% LVMUY 140.5 7.4488% XOM 111.18 -0.2959% LVMHF 703.0 7.5944% MA 523.165 0.156%
Last update at 2025-01-16T14:58:00Z
Genmab (GMAB) Upgraded to Buy: Here's What You Should Know
Tue 14 Jan 25, 05:00 PMAre Investors Undervaluing Genmab (GMAB) Right Now?
Tue 14 Jan 25, 02:40 PMHigh Growth Tech Stocks To Watch In January 2025
Tue 07 Jan 25, 01:04 AMGenmab to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Fri 03 Jan 25, 06:56 PMGenmab to Hold 2024 R&D Update and ASH Data Review Meeting
Wed 11 Dec 24, 01:20 PMWhy Is Genmab A/S (GMAB) Among the Best High Growth Healthcare Stocks to Invest In Now?
Mon 02 Dec 24, 07:43 PMWhy Is Genmab A/S (GMAB) Among the Worst Performing Healthcare Stocks in 2024?
Wed 27 Nov 24, 02:17 PMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
Income before tax | 7035.00M | 3983.00M | 5904.00M | 2859.00M | 1611.97M |
Minority interest | - | - | - | 0.00000M | 0.00000M |
Net income | 5522.00M | 3008.00M | 4758.00M | 2166.00M | 1472.14M |
Selling general administrative | 2676.00M | 1283.00M | 661.00M | 342.00M | 213.69M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 14595.00M | 8482.00M | 10111.00M | 5366.00M | 3025.14M |
Reconciled depreciation | 362.00M | 248.00M | 259.00M | 139.00M | 87.60M |
Ebit | 6357.00M | 3018.00M | 6313.00M | 2638.00M | 1612.39M |
Ebitda | 7043.00M | 3463.00M | 6756.00M | 2897.00M | 1699.98M |
Depreciation and amortization | 686.00M | 445.00M | 443.00M | 259.00M | 87.60M |
Non operating income net other | - | - | - | 0.00000M | 0.00000M |
Operating income | 6357.00M | 3018.00M | 6313.00M | 2638.00M | 1380.28M |
Other operating expenses | 8238.00M | 5464.00M | 3798.00M | 2728.00M | 1644.85M |
Interest expense | 21.00M | 13.00M | 10.00M | 7.00M | 0.42M |
Tax provision | 1513.00M | 975.00M | 1146.00M | 693.00M | 139.83M |
Interest income | 324.00M | 197.00M | 184.00M | 348.00M | 62.92M |
Net interest income | 303.00M | 184.00M | 174.00M | 334.00M | 62.51M |
Extraordinary items | - | - | - | 0.00000M | 0.00000M |
Non recurring | - | - | - | 0.00000M | 0.00000M |
Other items | - | - | - | 0.00000M | 0.00000M |
Income tax expense | 1513.00M | 975.00M | 1146.00M | 693.00M | 139.83M |
Total revenue | 14595.00M | 8482.00M | 10111.00M | 5366.00M | 3025.14M |
Total operating expenses | 8238.00M | 5464.00M | 3798.00M | 2728.00M | 1644.85M |
Cost of revenue | - | - | - | 0.00000M | 0.00000M |
Total other income expense net | 678.00M | 965.00M | -409.00000M | 221.00M | 231.69M |
Discontinued operations | - | - | - | 0.00000M | 0.00000M |
Net income from continuing ops | 5522.00M | 3008.00M | 4758.00M | 2166.00M | 1472.14M |
Net income applicable to common shares | 5522.00M | 3008.00M | 4758.00M | 2166.00M | 1472.00M |
Preferred stock and other adjustments | - | - | - | 0.00000M | 0.00000M |
Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 35289.00M | 30278.00M | 24627.00M | 21143.00M | 15144.00M |
Intangible assets | 101.00M | 146.00M | 254.00M | 338.00M | 470.00M |
Earning assets | - | - | - | - | - |
Other current assets | - | - | - | - | 10398.00M |
Total liab | 3679.00M | 2837.00M | 2431.00M | 2022.00M | 1096.00M |
Total stockholder equity | 31610.00M | 27441.00M | 22196.00M | 19121.00M | 14048.00M |